{
"@context": "/terms/",
"@id": "/human-beta-cell-line/PKBSM2542NXUU/",
"@type": [
"HumanBetaCellLines",
"Biosample",
"Sample",
"Item"
],
"accession": "PKBSM2542NXUU",
"age": "unknown",
"aliases": [
"pankbase-consortium:EndoC-bH1_treated_controlIFNa24hr_GSE202852"
],
"audit": {
"WARNING": [
{
"category": "incorrect classifications format",
"detail": "Human beta cell line [PKBSM2542NXUU](/human-beta-cell-line/PKBSM2542NXUU/) has `classifications` ['human beta cell line'] but should be [\"cell line\"]. Human beta cell lines are expected to have classifications as an array.",
"level": 40,
"level_name": "WARNING",
"name": "audit_classifications_format_check",
"path": "/human-beta-cell-line/PKBSM2542NXUU/"
}
]
},
"award": {
"@id": "/awards/U24DK138512-DK138515/",
"component": "data coordination"
},
"classifications": [
"human beta cell line"
],
"coating_condition": "Matrigel-fibronectin",
"creation_timestamp": "2025-10-21T18:43:27.861405+00:00",
"description": "EndoC-bH1 cells treated with control siRNA and IFNa for 24hr from GSE202852",
"donors": [
{
"@id": "/human-donors/PKBDO8293TLPA/",
"accession": "PKBDO8293TLPA",
"age": 0,
"summary": "PKBDO8293TLPA",
"taxa": "Homo sapiens"
}
],
"file_sets": [
{
"@id": "/analysis-sets/PKBDS7775GSUO/",
"accession": "PKBDS7775GSUO",
"aliases": [
"pankbase-consortium:EndoC-bH1_treated_controlIFNa24hr_GSE202852_AnalysisSet"
],
"lab": {
"title": "Pankbase Consortium, PanKbase"
},
"status": "released",
"summary": "intermediate analysis of RNA-seq data"
},
{
"@id": "/measurement-sets/PKBDS3726TJEX/",
"accession": "PKBDS3726TJEX",
"aliases": [
"pankbase-consortium:EndoC-bH1_treated_controlIFNa24hr_GSE202852_MeasurementSet"
],
"assay_term": {
"term_name": "bulk RNA-seq assay"
},
"lab": {
"title": "Pankbase Consortium, PanKbase"
},
"status": "released",
"summary": "bulk RNA-seq assay (RNA-seq)"
}
],
"growth_medium": "Dulbecco’s modified Eagle medium with 5.6 mM glucose, 2% fatty acid–free BSA fraction V, 50 μM 2-mercaptoethanol, 10 mM nicotinamide, transferrin, selenite (6.7 ng/ml), and penicillin (100 U/ml) + streptomycin (100 μg/ml)",
"institutional_certificates": [],
"lab": {
"@id": "/labs/pankbase-consortium/",
"title": "Pankbase Consortium, PanKbase"
},
"multiplexed_in": [],
"nucleic_acid_delivery": "Lipofectamine RNAiMAX",
"origin_of": [],
"parts": [],
"pooled_in": [],
"publication_identifiers": [
"PMID:36103539"
],
"release_timestamp": "2025-10-27T19:40:47.469925+00:00",
"sample_name": "EndoC-bH1",
"sample_terms": [
{
"@id": "/sample-terms/CVCL_909/",
"term_name": "EndoC-βH1"
}
],
"sorted_fractions": [],
"sources": [
{
"@id": "/sources/r-scharfmann-university-of-paris-france/",
"title": "R. Scharfmann, University of Paris, France"
}
],
"status": "released",
"submitted_by": {
"@id": "/users/5e3038c4-baa5-4589-b3d8-ad2fe634e826/",
"title": "Ying Sun"
},
"summary": "EndoC-βH1 cell line, depleted of negative control siRNA for 24 hours, treated with 2000 U/mL Interferon alpha for 24 hours",
"taxa": "Homo sapiens",
"treatments": [
{
"@id": "/treatments/7973c32c-1a59-4227-b3f8-84182d3c0fd7/",
"purpose": "control",
"status": "released",
"summary": "Depletion of negative control siRNA for 24 hours",
"treatment_type": "protein"
},
{
"@id": "/treatments/7faf5bfb-febc-444b-acf8-2dba9e0f2c31/",
"purpose": "stimulation",
"status": "released",
"summary": "Treatment of 2000 U/mL Interferon alpha for 24 hours",
"treatment_type": "protein"
}
],
"uuid": "bd5b1d41-3d3f-4a60-9de8-3fcedafbf167",
"virtual": false
}